To “deepen commercial and manufacturing expertise and position the company to capture full potential across businesses,” US generics player, ANI Pharmaceuticals, Inc., has hired three key executives including Christopher Mutz as chief commercial officer and head of rare diseases, Ori Gutwerg as senior vice president of generics and Davinder Singh as general manager, Canadian operations.
ANI president and CEO Nikhil Lalwani commented, “We are delighted to welcome Mutz, Gutwerg and Singh to ANI
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?